Dergiler / The European Research Journal / 2020 / Cilt: 6 - Sayı: 6

Frequency and predictors of access site complications of the transfemoral diagnostic coronary procedures

Sayfa
640–646
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Female gender, presence of CRF, using LMWH and long manual compression time were predictors of ASC.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Access site complications (ASC) remain important and common adverse events after coronary angiography.
📊
Temel Bulgular & Veri:Methods: In this prospective analytical cross sectional study, DCA was performed in 3972 patients by transfemoral approach.
💡
Sonuç & Katkı:Female gender, presence of CRF, using LMWH and long manual compression time were predictors of ASC.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Vascular access devices · coronary angiography · femoral artery

Abstract

Objectives: Access site complications (ASC) remain important and common adverse events after coronary angiography. The aim of this study was to evaluate the frequency and predictors of ASC in patients undergoing diagnostic coronary angiography (DCA) via the femoral artery. Methods: In this prospective analytical cross sectional study, DCA was performed in 3972 patients by transfemoral approach. The femoral access site hemostasis was obtained by manual compression in all patients. Demographic characteristics of the patients, size of the arterial sheaths, duration of compression time, patients blood pressure, medications, hemoglobin and platelet levels were recorded. All patients were evaluated for ASC (pseudoaneurysm, bleeding, dissection, hematoma). The ASC rate was calculated and ASC predictors were determined by multivariate analysis. Results: The ASC rate was 1.3% (53 of 3972 patients). The complications were more frequent in female (female: 29 of 53 [54.7%] vs male: 24 of 53 [45.3%]; p = 0.007) and chronic renal failure (CRF) patients (103 of 3919 [2.6%] vs 4 of 53 [7.5%]; p = 0.02). Hemoglobin level was lower (13.40 ± 1.73 vs 12.86 ± 1.75; p = 0.02) and manual compression time was longer (9.19 ± 3.28 min vs 14.53 ± 6.47 min; p < 0.001) in the ASC group. Clopidogrel (188 of 3919 [4.8%] vs 7 of 53 [13.2%]; p = 0.005) and low molecular weight heparin (LMWH) using were more frequent (37 of 3919 [0.9%] vs 7 of 53 [13.2%]; p < 0.001) in the ASC group. According to multivariate analysis; female gender; OR: 2.13, 95% CI: 1.14-3.99 (p = 0.017), presence of CRF; OR: 3.15, 95% CI: 1.06-9.29 (p = 0.038), manual compression time; OR: 1.23, 95% CI: 1.17-1.30 (p < 0.001) and LMWH using; OR: 15.68, 95% CI: 6.05-40.61 (p < 0.001) were predictors of ASC. Conclusions: The incidence of femoral ASC rate was 1.3% in patients with DCA. Female gender, presence of CRF, using LMWH and long manual compression time were predictors of ASC.

🔖

Bu Makaleye Atıf Yap

KARAKUŞ, A., ARI, S., ACAR, T., ARI, H., ÇAMCI, S., TÜTÜNCÜ, A., ÖZMEN, G., MELEK, M., DEMİR, M. (2020). Frequency and predictors of access site complications of the transfemoral diagnostic coronary procedures. The European Research Journal, Cilt: 6 - Sayı: 6, 640–646. https://ajindex.com/articles/364386

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Rajani NK, Brown AJ, Mccormick LM, Parwaiz H, Kaushal A, Hoole SP, et al. Institutional switch from transfemoral to transradial vascular access for percutaneous coronary intervention was associated with a reduction in bleeding events: a single center experience of > 10,000 consecutive cases. J Interv Cardiol 2015;28:296-304
  2. Fitts J, Ver Lee P, Hofmaster P, Malenka D, Group NNECS. Fluoroscopy‐guided femoral artery puncture reduces the risk of PCI‐related vascular complications. J Interv Cardiol 2008;21:273-8
  3. Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv 2005;65:196-202
  4. Wongcharoen W, Pinyosamosorn K, Gunaparn S, Boonnayhun S, Thonghong T, Suwannasom P, et al. Vascular access site complication in transfemoral coronary angiography between uninterrupted warfarin and heparin bridging. J Interv Cardiol 2017;30:387-92
  5. Bhatty S, Cooke R, Shetty R, Jovin IS. Femoral vascular access-site complications in the cardiac catheterization laboratory: diagnosis and management. Interv Cardiol 2011;3:503-14
  6. Ramana RK, Singh A, Dieter RS, Moran JF, Steen L, Lewis BE, et al. Femoral angiogram prior to arteriotomy closure device does not reduce vascular complications in patients undergoing cardiac catheterization. J Interv Cardiol 2008;21:204-8
  7. Tarighatnia A, Mohammadalian A, Ghojazade M, Pourafkari L, Farajollahi A. Beam projections and radiation exposure in transradial and transfemoral approaches during coronary angiography. Anatol J Cardiol 2017;18:298-303
  8. Bashore TM, Balter S, Barac A, Byrne JG, Cavendish JJ, Chambers CE, et al. 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 2012;59:2221-305
  9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41
  10. Rao AK, Pratt C, Berke A, Jaffe A, Ockene I, Schreiber TL, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial—phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988;11:1-11
  11. Ammann P, Brunner‐La Rocca HP,